208 related articles for article (PubMed ID: 20157841)
21. OSA Is a Risk Factor for Recurrent VTE.
Alonso-Fernández A; Suquia AG; de la Peña M; Casitas R; Pierola J; Barceló A; Soriano JB; Fernández-Capitán C; Martinez-Ceron E; Carrera M; García-Río F
Chest; 2016 Dec; 150(6):1291-1301. PubMed ID: 27452769
[TBL] [Abstract][Full Text] [Related]
22. Venous Thromboembolism Recurrence in Latvian Population: Single University Hospital Data.
Ģībietis V; Kigitoviča D; Strautmane S; Meilande K; Kalējs VR; Zaičenko A; Maķe K; Lejnieks A; Skride A
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31438542
[No Abstract] [Full Text] [Related]
23. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
Kearon C; Spencer FA; O'Keeffe D; Parpia S; Schulman S; Baglin T; Stevens SM; Kaatz S; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Moll S; Connors JM; Ginsberg JS; Spadafora L; Julian JA;
Ann Intern Med; 2015 Jan; 162(1):27-34. PubMed ID: 25560712
[TBL] [Abstract][Full Text] [Related]
24. Potential use of D-dimer measurement in patients treated with oral anticoagulant for a venous thromboembolic episode.
Ombandza-Moussa E; Samama MM; Horellou MH; Elalamy I; Conard J
Int Angiol; 2003 Dec; 22(4):364-9. PubMed ID: 15153820
[TBL] [Abstract][Full Text] [Related]
25. Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis.
Prandoni P; Vedovetto V; Ciammaichella M; Bucherini E; Corradini S; Enea I; Cosmi B; Mumoli N; Visonà A; Barillari G; Bova C; Quintavalla R; Zanatta N; Pedrini S; Villalta S; Camporese G; Testa S; Parisi R; Becattini C; Cuppini S; Pengo V; Palareti G;
Thromb Res; 2017 Jun; 154():35-41. PubMed ID: 28407492
[TBL] [Abstract][Full Text] [Related]
26. [Current criteria to determine the duration of anticoagulant therapy].
Palareti G
Recenti Prog Med; 2007 Dec; 98(12):603-6. PubMed ID: 18369033
[TBL] [Abstract][Full Text] [Related]
27. Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.
Cosmi B; Legnani C; Iorio A; Pengo V; Ghirarduzzi A; Testa S; Poli D; Tripodi A; Palareti G;
Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):356-65. PubMed ID: 20034816
[TBL] [Abstract][Full Text] [Related]
28. A significant decrease in D-dimer concentration within one month of anticoagulation therapy as a predictor of both complete recanalization and risk of recurrence after initial pulmonary embolism.
Aranda C; Peralta L; Gagliardi L; López A; Jiménez Á; Herreros B
Thromb Res; 2021 Jun; 202():31-35. PubMed ID: 33711756
[TBL] [Abstract][Full Text] [Related]
29. The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study).
Ageno W; Cosmi B; Ghirarduzzi A; Santoro R; Bucherini E; Poli D; Prisco D; Alatri A; Pengo V; Galli L; Dentali F; Palareti G
Am J Hematol; 2012 Jul; 87(7):713-5. PubMed ID: 22488507
[TBL] [Abstract][Full Text] [Related]
30. High incidence of silent venous thromboembolism before treatment in ovarian cancer.
Satoh T; Oki A; Uno K; Sakurai M; Ochi H; Okada S; Minami R; Matsumoto K; Tanaka YO; Tsunoda H; Homma S; Yoshikawa H
Br J Cancer; 2007 Oct; 97(8):1053-7. PubMed ID: 17895896
[TBL] [Abstract][Full Text] [Related]
31. The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study.
van Hylckama Vlieg A; Baglin CA; Luddington R; MacDonald S; Rosendaal FR; Baglin TP
J Thromb Haemost; 2015 Sep; 13(9):1642-52. PubMed ID: 26178257
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: A Post-hoc Analysis of the PADIS-PE trial.
Raj L; Presles E; Le Mao R; Robin P; Sanchez O; Pernod G; Bertoletti L; Jego P; Lemarié CA; Leven F; Hoffmann C; Planquette B; Le Roux PY; Slaun PY; Nonent M; Girard P; Lacut K; Mélac S; Guégan M; Mismetti P; Laporte S; Meyer G; Leroyer C; Tromeur C; Couturaud F;
Am J Med; 2020 Aug; 133(8):e406-e421. PubMed ID: 32333853
[TBL] [Abstract][Full Text] [Related]
33. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
Couturaud F; Sanchez O; Pernod G; Mismetti P; Jego P; Duhamel E; Provost K; dit Sollier CB; Presles E; Castellant P; Parent F; Salaun PY; Bressollette L; Nonent M; Lorillon P; Girard P; Lacut K; Guégan M; Bosson JL; Laporte S; Leroyer C; Décousus H; Meyer G; Mottier D;
JAMA; 2015 Jul; 314(1):31-40. PubMed ID: 26151264
[TBL] [Abstract][Full Text] [Related]
34. [Follow-up of pulmonary thromboembolism].
Uresandi F; Iruin G; Gómez B; Uresandi A
Med Clin (Barc); 2008 Nov; 131 Suppl 2():54-9. PubMed ID: 19087852
[TBL] [Abstract][Full Text] [Related]
35. Accuracy of clinical decision rule, D-dimer and spiral computed tomography in patients with malignancy, previous venous thromboembolism, COPD or heart failure and in older patients with suspected pulmonary embolism.
Sohne M; Kruip MJ; Nijkeuter M; Tick L; Kwakkel H; Halkes SJ; Huisman MV; Buller HR;
J Thromb Haemost; 2006 May; 4(5):1042-6. PubMed ID: 16689757
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the Incidence of Chronic Thromboembolic Pulmonary Hypertension 1 Year After First Episode of Acute Pulmonary Embolism: A Cohort Study.
Rashidi F; Parvizi R; Bilejani E; Mahmoodian B; Rahimi F; Koohi A
Lung; 2020 Feb; 198(1):59-64. PubMed ID: 31894412
[TBL] [Abstract][Full Text] [Related]
37. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
[TBL] [Abstract][Full Text] [Related]
38. Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.
Willey VJ; Bullano MF; Hauch O; Reynolds M; Wygant G; Hoffman L; Mayzell G; Spyropoulos AC
Clin Ther; 2004 Jul; 26(7):1149-59. PubMed ID: 15336480
[TBL] [Abstract][Full Text] [Related]
39. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
[TBL] [Abstract][Full Text] [Related]
40. Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism.
Dentali F; Donadini M; Gianni M; Bertolini A; Lonn E; Venco A; Cattozzo G; Ageno W
Intern Emerg Med; 2009 Apr; 4(2):123-8. PubMed ID: 19247590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
